Local HER-O
17 Dec 2020
Trial Summary
This study aims to show that brain metastases from Human Epidermal Growth Factor Receptor Type 2 (HER2) positive breast cancers are able to be controlled by local therapies, Stereotactic Radiosurgery (SRS) and/or Neurosurgery (NS).
Acronym:
Local HER-O
ACTRN/NCT /ethics:
NCT02898727
Scientific title:
A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer
Sponsor / Cooperative group:
TROG Cancer Research
Trial & Patient Characteristics
| Cancer Type | Breast |
|---|---|
| Trial Type | Treatment |
| Phase | Phase II |
| Age Range | 18 years and older |
| Sex | Both |
| Tumour Stream | - |
| Cancer Stage | Metastatic or Widespread |
| Anticipated Start Date | 2017-11-20 |
| Anticipated End Date | 2020-05-01 |
Participating Hospitals
| Hospital | Royal Adelaide Hospital |
|---|---|
| Clinical Trial Coordinator | Anne Milton |
| anne.milton@sa.gov.au | |
| Phone | 08 7074 2342 |
| Principal Investigator | Professor Hui Tee |
| Recruitment Status | Recruiting |